​

AlphaTON Capital Stock (NASDAQ:ATON)

ForecastFinancialsChart
AlphaTON Capital by TradingView

Previous Close

$5.23

52W Range

$2.95 - $15.82

50D Avg

$6.46

200D Avg

$6.35

Market Cap

$11.76M

Avg Vol (3M)

$832.14K

Beta

0.60

Div Yield

-

ATON Company Profile

AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.

Show More

Industry

Asset Management

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Jan 02, 2002

Website

ATON Performance

ATON Financial Summary

Mar 24Mar 23Mar 22
Revenue---
Operating Income$-18.25M$-16.57M$-15.59M
Net Income$-75.34M$-104.61M$-16.87M
EBITDA$-18.20M$-15.78M$-15.59M
Basic EPS$-3.70$-6.49$-1.29
Diluted EPS$-3.70$-6.49$-1.29

Fiscal year ends in Mar 24 | Currency in USD

Peer Comparison

TickerCompany
SVACSpring Valley Acquisition Corp. III Class A Ordinary Shares
NPACNew Providence Acquisition Corp. III
IPCXInflection Point Acquisition Corp. III
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary Shares
CARVCarver Bancorp, Inc.
NISNNisun International Enterprise Development Group Co., Ltd
MIGIMawson Infrastructure Group, Inc.